Moonrise Medical
Moonrise Medical is dedicated to developing AI-enabled ultrasound technology aimed at improving the diagnosis and treatment of peripheral vascular diseases, particularly focusing on conditions like Peripheral Artery Disease (PAD) and Diabetic Foot Ulcers (DFU). Their innovative approach seeks to enhance wound healing and prevent amputations through accurate and timely vascular assessments.
Moonrise Medical
295 Robinson St. Suite 100, Oakville, Ontario L6J 1G7, Canada
What We Do
AI-enabled Ultrasound Device
An AI-enabled ultrasound-based device designed to evaluate flow hemodynamics in the peripheral vascular system, specifically targeting Peripheral Artery Disease (PAD) and Diabetic Foot Ulcers (DFU).
Diagnostics
Key People
Adam Gold
Chief Executive Officer
Abubaker Khalifa, MD
Chief Operating Officer
Jill Sommerset, RVT
Chief Scientific Officer